Federated Hermes
GMAB icon

Federated Hermes’s Genmab GMAB Stock Holding History

Federated Hermes’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.8M Buy
1,449,376
+197,786
+16% +$5.26M 0.06% 316
2026
Q1 		$33.6M Buy
1,251,590
+572,211
+84% +$17.1M 0.05% 351
2025
Q4 		$20.9M Buy
679,379
+256,441
+61% +$7.99M 0.04% 450
2025
Q3 		$13M Buy
+422,938
New +$10.3M 0.02% 508
2023
Q4 		– Sell
-4,686
Closed -$165K – 2098
2023
Q3 		$165K Buy
4,686
+8
+0.2% +$305 ﹤0.01% 1549
2023
Q2 		$178K Sell
4,678
-34,360
-88% -$1.37M ﹤0.01% 1563
2023
Q1 		$1.47M Sell
39,038
-645,540
-94% -$24.8M ﹤0.01% 1054
2022
Q4 		$29M Buy
684,578
+119,990
+21% +$4.94M 0.08% 296
2022
Q3 		$18.1M Sell
564,588
-13,145
-2% -$462K 0.05% 404
2022
Q2 		$18.8M Sell
577,733
-85,682
-13% -$2.78M 0.05% 400
2022
Q1 		$24M Sell
663,415
-26,524
-4% -$910K 0.05% 396
2021
Q4 		$27.3M Buy
689,939
+878
+0.1% +$36.6K 0.05% 414
2021
Q3 		$30.1M Sell
689,061
-6,561
-0.9% -$295K 0.06% 388
2021
Q2 		$28.4M Sell
695,622
-218,948
-24% -$8.45M 0.05% 401
2021
Q1 		$30M Sell
914,570
-112,008
-11% -$4.21M 0.06% 389
2020
Q4 		$41.7M Sell
1,026,578
-171
-0% -$6.39K 0.09% 292
2020
Q3 		$37.6M Buy
1,026,749
+1,287
+0.1% +$46.5K 0.09% 262
2020
Q2 		$34.8M Sell
1,025,462
-38,285
-4% -$1.04M 0.09% 272
2020
Q1 		$22.5M Sell
1,063,747
-71,694
-6% -$1.6M 0.07% 317
2019
Q4 		$25.4M Buy
1,135,441
+154,900
+16% +$3.38M 0.06% 353
2019
Q3 		$19.9M Buy
+980,541
New +$19.3M 0.05% 372

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Federated Hermes's GMAB Position: Q2 2026 in Review

Federated Hermes increased its Genmab (GMAB) stake by 16% in Q2 2026, buying an estimated $5.26M and bringing the position to 1,449,376 shares worth $39.8M. The position accounts for 0.06% of the portfolio, ranked #316.

Federated Hermes first reported a position in GMAB in Q3 2019 and has held it in 21 quarters since. The position peaked at $41.7M in Q4 2020. 292 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Federated Hermes held 1,449,376 shares of Genmab worth $39.8M as of Q2 2026.
  • Federated Hermes bought 197,786 Genmab shares in Q2 2026, an estimated $5.26M.
  • Genmab made up 0.06% of Federated Hermes's portfolio in Q2 2026, its #316 holding.
  • Federated Hermes first reported a position in Genmab in Q3 2019 and has held it in 21 quarters since.
  • Federated Hermes's Genmab position peaked at $41.7M in Q4 2020.
  • 292 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.